Outbreak of Candida auris infection in a COVID-19 hospital in Mexico

Hiram Villanueva-Lozano,Rogelio de J Treviño-Rangel,Gloria M González,María Teresa Ramírez-Elizondo,Reynaldo Lara-Medrano,Mary Cruz Aleman-Bocanegra,Claudia E Guajardo-Lara,Natalia Gaona-Chávez,Fernando Castilleja-Leal,Guillermo Torre-Amione,Michel F Martínez-Reséndez,Rogelio de J. Treviño-Rangel,Gloria M. González,Claudia E. Guajardo-Lara,Michel F. Martínez-Reséndez
DOI: https://doi.org/10.1016/j.cmi.2020.12.030
IF: 13.31
2021-05-01
Clinical Microbiology and Infection
Abstract:<p>The aim of this study was to describe the clinical and microbiological characteristics of twelve patients with severe COVID-19 and Candida auris co-infection.</p><p>Microbiological characterization of the isolates consisting on molecular identification, genotypification through multilocus sequence typing and antifungal susceptibility to eight antifungals was performed.</p><p>Mortality among patients with COVID-19 and C. auris candidaemia was of 83.3% even with the use of appropriate antifungal therapy. All the isolates studied were resistant to amphotericin B.</p><p>Causes related to the incidence of COVID-19 and candidaemia are not well understood but seems to be related to common contributing factor seen in critically-ill patients; nonetheless, the high mortality reported demands close attention to patients who present this co-infection.</p>
infectious diseases,microbiology
What problem does this paper attempt to address?